|
Mr. Heyman, who joined the Company at its inception in August 2001, has 28 years of experience, from 1964 to 1993, as a drug and biotech analyst for Lord Abbett & Co., a major investment firm. He has 10 years of experience in the drug and chemical industry as a chemical engineer with American Cyanamid, Lummus and Esso Research and Engineering. Mr. Heyman has extensive startup experience with a variety of enabling technology companies in the drug (chemical libraries, urokinase plasmingogen activation receptors), advanced protein separation science, fermentation, materials science (metal/ceramic binding), medical software (clinical data capture) and device (ultrasonography) fields. Mr. Heyman maintains wide contacts in the drug, biotech industry, and the investment community. He has a B.S. Ch. Eng. from Lafayette College and an M.B.A. from Rutgers. He was Chairman of Securitron, the world's leading electromagnetic lock company, and played a key role in its growth and eventual sale to the Swedish company Assay Abloy. | 